Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Discussion – Supportive and palliative care

5591 - Worse Patient- Physician Relationship Is Associated With More Fear Of Cancer Recurrence (Deimos Study): A Study Of The Palliative Care Working Committee Of The Turkish Oncology Group (TOG)

Date

28 Sep 2019

Session

Poster Discussion – Supportive and palliative care

Presenters

Ali Alkan

Citation

Annals of Oncology (2019) 30 (suppl_5): v667-v670. 10.1093/annonc/mdz262

Authors

A. Alkan1, A. Yaşar2, Z.G. Güç3, M. Gürbüz4, T. Başoğlu5, S. Sezgin Göksu6, F. Buğdaycı Başal7, H.M. Türk8, Ö. Özdemir9, H. Yeşil Çınkır10, D.C. Güven11, T. Kuş12, S. Türker13, L. Koral14, Y. Karakaş15, N. Ak16, S. Paydaş17, E. Karcı18, Ö. Tanrıverdi1, F. Çay Şenler2

Author affiliations

  • 1 Medical Oncology, Muğla Sıtkı Koçman University School of Medicine, 48000 - Muğla/TR
  • 2 Medical Oncology, Ankara University School of Medicine, 80350 - Ankara/TR
  • 3 Medical Oncology, Dokuz Eylül University School of Medicine, 80350 - İzmir/TR
  • 4 Medical Oncology, Ankara University School of Medicine, 80350 - ANKARA/TR
  • 5 Medical Oncology, Marmara University School of Medicine, 80350 - İstanbul/TR
  • 6 Medical Oncology, Akdeniz University School of Medicine, 80350 - Antalya/TR
  • 7 Medical Oncology, Abdurrahman Yurtarslan Research and Training Hospital, 80350 - Ankara/TR
  • 8 Medical Oncology, Bezmialem University School of Medicine, 80350 - İstanbul/TR
  • 9 Medical Oncology, İzmir Bozyak Research and Training Hospital, 80350 - İzmir/TR
  • 10 Medical Oncology, Gaziantep University School of Medicine, 80350 - GAziantep/TR
  • 11 Medical Oncology, Hacettepe University School of Medicine, 80350 - Ankara/TR
  • 12 Medical Oncology, Adıyaman Research and Training Hospital, 80350 - Adıyaman/TR
  • 13 Medical Oncology, DIŞKAPI YILDIRIM BEYAZIT Research and Training Hospital, 80350 - Ankara/TR
  • 14 Medical Oncology, Çanakkale Onsekiz MArt University School of Medicine, 80350 - Çanakkale/TR
  • 15 Medical Oncology, Bodrum Acıbadem Hospital, 80350 - Muğla/TR
  • 16 Medical Oncology, İstanbul University School of Medicine, 80350 - İstanbul/TR
  • 17 Medical Oncology, Çukurova University School of Medicine, 48000 - Adana/TR
  • 18 Medical Oncology, Bağcılar Research and Training Hospital, 80350 - İstanbul/TR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 5591

Background

Fear of cancer recurrence (FCR) is an important psychological trauma that has been associated with reduction in the quality of life, disruptions in the level of adjustment, emotional distress and anxiety. The purpose of the study is to evaluate the impact of patient–physician relationship on FCR.

Methods

The study was designed as a multicenter survey study. The cancer survivors who were under remission, were evaluated with structured questionnaires. Patient–physician relationship (PPR) scale in which higher scores indicate better relationship and FCR inventory were used.

Results

Between January-April 2019, 1580 patients were evaluated. The median age was 57.0(19-88) and 66% were female. There was high level of FCR scores in 51% of participants. There was a negative correlation between PPR and FCR scores (r= -0.134, p < 0.001). In multivariate analysis; young age (OR = 1.46 CI(95%) 1.1-1.8, p = 0.002), female gender (OR = 1.93 CI(95%) 1.5-2.4, p < 0.001), history of non-routine imaging (OR = 1.8 CI(95%) 1.4-2.4, p < 0.001) and worse PPR (OR = 1.31 CI(95%) 1.07-1.6, p = 0.009) were associated with high levels of FCR.Table: 1617PD

The multivariate analysis of factors associated with high FCR scores

High FCR scores
ORCI(95%)p
Young age(<65)1.461.1-1.80.002
Female gender1.931.5-2.4<0.001
History of non-routine imaging1.891.4-2.4<0.001
Worse PPS1.311.07-1.60.009

Conclusions

It is the first data showing the adverse impact of worse PPR on FCR. The strategies to improve the PPR should be practiced. In addition, the cancer survivors who are under the risk of FCR, should be evaluated and managed.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Ali Alkan.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.